Feedback tool to help men with prostate cancer decide on treatment
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a computer tool that analyzes your conversations with doctors. It aims to help you make a more informed choice about prostate cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with localized prostate cancer that hasn't spread
- You are about to discuss treatment options with your doctor for the first time
- OR you have been on active surveillance and are now considering definite treatment like surgery or radiation
- You can read and write in English
- You are 18 years or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an English computer tool that gives feedback during prostate cancer treatment visits. It aims to help you and your clinician make more informed, shared decisions about next treatment steps.
This trial tests if an AI tool can help you better understand your prostate cancer diagnosis results. If you recently had a prostate biopsy at Cleveland Clinic but haven't discussed the results yet, this study may help you get clear information.
This trial tests an English decision aid (a patient guide) to help older men understand and feel comfortable with “active surveillance” for localized prostate cancer. It also checks how easy to use it is for patients, caregivers, and prostate cancer clinicians.
This trial tests visual tools to help surgeons make better decisions for patients with early-stage prostate or kidney cancer. It may help you and your doctor choose the best treatment.
This trial uses a computer program (large language model) to help doctors read Chinese PSMA PET/CT reports. The goal is to see if the AI can accurately identify key details about prostate cancer, like where it has spread, which may help make staging and treatment decisions faster.
This study tests if an AI tool can improve the safety review of radiation treatment plans for prostate cancer. Patients continue their normal treatment while the AI helps doctors check the plans.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.